ResearcherChiba UniversityNo recent work listed
Mamoru Satoh
Matched on ORCID iD 0000-0002-2165-3153; OpenAlex author ID A5012393967. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper
Papers 5
- Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. Co-author DOI 10.1007/s13402-021-00614-z↗
- Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. Co-author DOI 10.1111/cas.13181↗
- Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags. Co-author DOI 10.1038/bjc.2016.295↗
- Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells. Co-author DOI 10.1016/j.jss.2012.05.065↗
- The application of a three-step proteome analysis for identification of new biomarkers of pancreatic cancer. Co-author DOI 10.1155/2011/628787↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Masaru Miyazaki · 5 shared papers, 2011–2021 · strength 0.27
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Paper Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. DOI 10.1111/cas.13181↗
- Paper Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative pr… DOI 10.1038/bjc.2016.295↗
- Shigetsugu Takano · 5 shared papers, 2011–2021 · strength 0.27
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Paper Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. DOI 10.1111/cas.13181↗
- Paper Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative pr… DOI 10.1038/bjc.2016.295↗
- Fumio Nomura · 5 shared papers, 2011–2021 · strength 0.27
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Paper Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. DOI 10.1111/cas.13181↗
- Paper Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative pr… DOI 10.1038/bjc.2016.295↗
- Hideyuki Yoshitomi · 5 shared papers, 2011–2021 · strength 0.27
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Paper Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. DOI 10.1111/cas.13181↗
- Paper Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative pr… DOI 10.1038/bjc.2016.295↗
- Kazuyuki Sogawa · 4 shared papers, 2011–2021 · strength 0.24
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Paper Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. DOI 10.1111/cas.13181↗
- Paper Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative pr… DOI 10.1038/bjc.2016.295↗
- Masayuki Ohtsuka · 3 shared papers, 2012–2021 · strength 0.18
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Paper Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative pr… DOI 10.1038/bjc.2016.295↗
- Paper Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells. DOI 10.1016/j.jss.2012.05.065↗
- Shingo Kagawa · 2 shared papers, 2012–2021 · strength 0.14
- Katsunori Furukawa · 2 shared papers, 2012–2021 · strength 0.14
- Reiri Shimazaki · 1 shared paper, 2021 · strength 0.11
- Yoji Miyahara · 1 shared paper, 2021 · strength 0.11
- Kosuke Sasaki · 1 shared paper, 2021 · strength 0.11
- Masayuki Otsuka · 1 shared paper, 2017 · strength 0.06
- Osamu Yokosuka · 1 shared paper, 2016 · strength 0.05
- Rintaro Mikata · 1 shared paper, 2016 · strength 0.05
- Mayinuer Abulaizi · 1 shared paper, 2011 · strength 0.02
- Takeshi Tomonaga · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.